Thus, in lupus-prone mice, SCFAs dampen B cell AID and Blimp1 expression, plasma cell differentiation, systemic class-switched autoantibodies, and abolish lupus skin lesions and kidney pathology. The gene discussed is AICDA; the disease is systemic lupus erythematosus.